evidencegaps
Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

4 questions · 4 findings · 1 reviews

Sort:Best matchNewestHighest certaintyDownload CSV
No studies found 0 · 0%GRADE not reported 0 · 0%Very low 4 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

L‐ornithine L‐aspartate vs probiotic

Hepatic encephalopathy · people with cirrhosis who had minimal or overt hepatic encephalopathy or who were at risk for developing hepatic encephalopathy;…

It is very uncertain whether L‐ornithine L‐aspartate changes hepatic encephalopathy assessed based on neurocognitive manifestations compared with probiotic (very low certainty).

1 finding from 1 review

L‐ornithine L‐aspartate vs rifaximin

Hepatic encephalopathy · people with cirrhosis who had minimal or overt hepatic encephalopathy or who were at risk for developing hepatic encephalopathy;…

It is very uncertain whether L‐ornithine L‐aspartate changes hepatic encephalopathy assessed based on neurocognitive manifestations compared with rifaximin (very low certainty).

1 finding from 1 review

L‐ornithine L‐aspartate vs lactulose

Hepatic encephalopathy · people with cirrhosis who had minimal or overt hepatic encephalopathy or who were at risk for developing hepatic encephalopathy;…

It is very uncertain whether L‐ornithine L‐aspartate changes hepatic encephalopathy assessed based on neurocognitive manifestations compared with lactulose (very low certainty).

1 finding from 1 review

L‐ornithine L‐aspartate vs placebo or no intervention

Hepatic encephalopathy

It is very uncertain whether L‐ornithine L aspartate changes hepatic encephalopathy assessed based on neurocognitive manifestations compared with placebo or no intervention (very low certainty).

1 finding from 1 review